Skip to main content
Caplight Logo









Beech Biotech SA

Beech Biotech SA

Private
LausanneHealthcare & Life Scienceshttps://beech-biotech.com/

Last Round

Pre Seed

Apr 2, 2026

Total Funding Raised

$2.94M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Beech Biotech SA is a biopharmaceutical company developing placenta-impermeable monoclonal antibodies to treat pregnancy complications such as preeclampsia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodypreeclampsiamaternal healthplacenta-impermeablebiopharmaceutical R&Ddrug developmentmother-only therapypregnancy complicationsvirtual biotechtherapeutic platforminvestigational new drugINDwomen's health techfemtechbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beech Biotech SA Comparables

Compare Beech Biotech SA with similar companies based on industry and business-model similarity.

Beech Biotech SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Comanche Biopharma
82%
MirZyme Therapeutics
78%
Corion Biotech
72%

Beech Biotech SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 2, 2026
GrantJun 27, 2025
AcceleratorMar 5, 2025

Beech Biotech SA Investors

Notable investors and investment history

Beech Biotech SA investors
InvestorRounds
Bill & Melinda Gates FoundationGrant
Mission BioCapitalPre Seed
BioInnovation InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    $500K round led by Mission BioCapital

  • Jun 27, 2025

    $2M grant from the Bill & Melinda Gates Foundation

Beech Biotech SA Filings

Explore SEC and related filing metadata, where available.

Beech Biotech SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Beech Biotech SA's valuation, stock price, and market status.

Is Beech Biotech SA a public or private company?

Beech Biotech SA is a private company.

What is the current stock price of Beech Biotech SA?

Beech Biotech SA is a private company with no public stock price. No recent secondary market data is available.

How much is Beech Biotech SA worth (valuation)?

Valuation information for Beech Biotech SA is not publicly available.

Can I buy Beech Biotech SA stock?

Beech Biotech SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Beech Biotech SA's last funding round?

Beech Biotech SA's most recent funding round was Pre Seed on April 2, 2026.

Who are the main investors in Beech Biotech SA?

Key investors in Beech Biotech SA include Mission BioCapital, BioInnovation Institute.

Will Beech Biotech SA IPO soon?

No public IPO plans have been announced for Beech Biotech SA.

How can I track Beech Biotech SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beech Biotech SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLausanne
Employee Range2
Year Founded2022
Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?